Inozyme Pharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $1,976 |
Gross Profit | -188 | -182 | 1,670 |
EBITDA | -25,450 | -21,840 | -17,905 |
EBIT | -25,638 | -22,022 | -18,211 |
Net Income | -27,033 | -23,347 | -21,544 |
Net Change In Cash | 0 | 0 | 1,976 |
Free Cash Flow | -23,658 | -24,565 | -18,592 |
Cash | 15,233 | 20,618 | 34,588 |
Basic Shares | 61,943 | 61,772 | 61,768 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,294 | -1,177 | -1,052 | -217 |
EBITDA | -74,812 | -67,931 | -55,972 | -56,824 |
EBIT | -75,645 | -68,675 | -57,024 | -57,041 |
Net Income | -71,169 | -65,447 | -56,413 | -55,837 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 9,624 | -4,724 | -3,341 | |
Free Cash Flow | -70,973 | -58,171 | -48,550 | -36,542 |
Cash | 34,588 | 32,915 | 23,316 | 159,896 |
Basic Shares | 51,839 | 37,763 | 23,558 | 23,384 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.39 |
2024-06-30 | -$0.44 |
2024-03-31 | -$0.38 |
2023-12-31 | -$0.33 |
